针对有限阶段小细胞肺癌的免疫疗法:创新的治疗方法和未来前景
Xiaoni Jin1, Weixing Zhao1, Guoyuan Li2
1Department of Oncology, Graduate School of Qinghai University, Xining, China.
Cancer control : journal of the Moffitt Cancer Center
|April 14, 2025
概括
免疫检查点抑制剂 (ICI) 在改善有限阶段小细胞肺癌 (LS-SCLC) 的存活率方面表现有前途. 需要进一步的研究来优化治疗方案,并确定可预测的生物标志物,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 肺部病理学 肺部病理学
背景情况:
- 局限期小细胞肺癌 (LS-SCLC) 是一种具有不良预后的侵袭性恶性瘤.
- 同时化疗放射治疗 (CCRT) 是标准治疗方法,但复发率很高.
- 对于LS-SCLC,迫切需要新的治疗策略.
研究的目的:
- 审查免疫检查点抑制剂 (ICI) 在LS-SCLC治疗中的临床进展.
- 突出ICI在改善无进展生存 (PFS) 和整体生存 (OS) 的潜力.
- 讨论与免疫治疗相关的副作用的管理.
主要方法:
- 这是一篇综述文章,综合了对LS-SCLC免疫治疗的最新研究.
- 总结了关于ICI在CCRT,整合和新辅助疗法中的应用的关键研究.
- 研究了瘤微环境,瘤突变负担 (TMB) 和PD-L1等生物标志物的作用.
主要成果:
- ICI在改善LS-SCLC患者的PFS和OS方面显示出潜力.
- 该审查综合了不同治疗环境中ICI疗效的研究结果.
- 生物标志物正在研究以预测免疫疗法反应.
结论:
- 取得了重大进展,但优化LS-SCLC的ICI治疗方案仍然存在挑战.
- 验证长期疗效和开发个性化的预测生物标志物至关重要.
- 未来的研究应该专注于大规模试验,以改进组合策略并提高患者的治疗结果.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
506
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
Cancer Vaccines
259
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
259
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
